Top in rheumatology: Adalimumab biosimilar approval; the immunopathophysiology of PsA - Healio

1 year ago 64

December 23, 2022

1 min work

ADD TOPIC TO EMAIL ALERTS

Receive an email erstwhile caller articles are posted connected

Please supply your email code to person an email erstwhile caller articles are posted connected .

We were incapable to process your request. Please effort again later. If you proceed to person this contented delight interaction customerservice@slackinc.com.

The FDA approved Idacio arsenic a biosimilar to Humira, a TNF inhibitor with indications for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis and plaque psoriasis.

According to the manufacturer, Idacio (adalimumab-aacf, Fresenius Kabi) is simply a citrate-free formulation of Humira (adalimumab, AbbVie). It was the apical communicative successful rheumatology past week.

Image of arthritic hand The FDA has approved Idacio arsenic a biosimilar to Humira, a TNF inhibitor with indications for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis and plaque psoriasis. Source: Adobe Stock

The 2nd apical communicative explored the mechanics of enactment by which psoriatic arthritis attraction works.

Read these and much apical stories successful rheumatology below:

FDA approves Fresenius Kabi’s Idacio arsenic eighth adalimumab biosimilar

The FDA has approved Idacio arsenic the eighth biosimilar to adalimumab, for each eligible indications of the notation product, clearing the mode for its U.S. merchandise successful 2023 alongside a deluge of different Humira biosimilars. Read more.

Understanding the immunopathophysiology of PsA

Understanding the mechanics of enactment by which psoriatic arthritis attraction works and taking a patient’s manner into relationship tin payment clinicians treating patients with the condition, said Philip J. Mease, MD, of the Swedish Medical Center successful Seattle and the University of Washington. Read more.

Patients with IMIDs, myocardial infarction astatine higher hazard for death, bosom failure

Patients with rheumatic immune-mediated inflammatory illness who acquisition myocardial infarction are much apt to dice oregon acquisition bosom nonaccomplishment vs. patients without immune-mediated inflammatory disease, according to data. Read more.

Cigna Pharmacy to database adalimumab biosimilars astatine aforesaid terms constituent arsenic originator

Cigna Pharmacy announced that it volition adhd adalimumab biosimilars arsenic “preferred products” astatine the aforesaid terms level arsenic the originator Humira connected its commercialized formularies, according to a institution property release. Read more.

Lorecivivint delays osteoarthritis structural progression successful semipermanent hold study

Repeat injections of the Wnt pathway inhibitor lorecivivint (SM04690, Biosplice) appears to person slowed the diminution of medial associated abstraction width successful genu osteoarthritis, according to interim results from a semipermanent hold proceedings released by Biosplice. Read more.

ADD TOPIC TO EMAIL ALERTS

Receive an email erstwhile caller articles are posted connected

Please supply your email code to person an email erstwhile caller articles are posted connected .

We were incapable to process your request. Please effort again later. If you proceed to person this contented delight interaction customerservice@slackinc.com.

Read Entire Article